Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Insect Biochemistry and Molecular Biology|December 3, 2014
Re-examination of a α-chymotrypsin-solubilized laccase in the pupal cuticle of the silkworm, Bombyx mori: Insights into the regulation system for laccase activation during the ecdysis processTsunaki Asano, Masato Taoka, Yoshio Yamauchi, et al.
Microbiology Spectrum|October 27, 2025
Comparative genomics of Nocardia tsunamiensis IFM 10818, a new source of the antibacterial macrolide nargenicin A1Yu Lu, Yosuke Seto, Yasumasa Hara, et al.
Elife|May 10, 2021
Chromatin structure-dependent histone incorporation revealed by a genome-wide deposition assayHiroaki Tachiwana, Mariko Dacher, Kazumitsu Maehara, et al.
Frontiers in Nutrition|May 14, 2026
Oral supplementation with piceatannol improves skin hydration and reduces wrinkle severity: a randomized, double-blind, placebo-controlled trialYosuke Seto, Motoki Tsukiashi, Takumi Yamaguchi, et al.
Journal of Fungi (Basel, Switzerland)|April 28, 2023
Fusarium mindanaoense sp. nov., a New Fusarium Wilt Pathogen of Cavendish Banana from the Philippines Belonging to the F. fujikuroi Species ComplexShunsuke Nozawa, Yosuke Seto, Yoshiki Takata, et al.
Thoracic Cancer|January 17, 2020
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non-small cell lung cancerKen Takahashi, Yosuke Seto, Koutaroh Okada, et al.
Oncogene|July 24, 2021
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasisSatoshi Takagi, Yuki Sasaki, Sumie Koike, et al.
Oncogene|December 11, 2024
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcomaSatoshi Takagi, Mikako Nakajima, Sumie Koike, et al.
JCI Insight|December 7, 2021
Soluble PD-L1 works as a decoy in lung cancer immunotherapy via alternative polyadenylationRay Sagawa, Seiji Sakata, Bo Gong, et al.
NPJ Precision Oncology|April 17, 2021
Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivityTakahiro Yoshizawa, Ken Uchibori, Mitsugu Araki, et al.
Pageof 3